Celecoxib Pathway, Pharmacodynamics

No Pathway Network information available for Celecoxib Pathway, Pharmacodynamics

Pathways in the Celecoxib Pathway, Pharmacodynamics SuperPath

#	Name	Source	Genes
1	Celecoxib Pathway, Pharmacodynamics	PharmGKB	AKR1C3 AKT1 ATP2A1 ATP2A2 ATP2A3 BCAR1 CA12 CA9 CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CACNA1G CACNA1H CACNA1I CACNA1S CACNA2D1 CACNA2D2 CACNA2D3 CACNA2D4 CACNB1 CACNB2 CACNB3 CACNB4 CASP3 CASP9 CDKN1A CDKN1B CTNNB1 DDIT3 HPGDS IGFBP3 KCNQ1 KCNQ2 KCNQ3 KCNQ4 KCNQ5 MMP9 PDK1 PLA2G2A PLA2G4A PPARG PTGDR PTGER1 PTGER2 PTGER3 PTGER4 PTGES PTGFR PTGIR PTGIS PTGS1 PTGS2 TBXA2R TBXAS1 VEGFA (see all 58) (see less)

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

#	Symbol	Description	Category	# Related Pathways
1	PTGDR	Prostaglandin D2 Receptor	Protein Coding	1
2	PTGER1	Prostaglandin E Receptor 1	Protein Coding	1
3	PTGER2	Prostaglandin E Receptor 2	Protein Coding	1
4	PTGER3	Prostaglandin E Receptor 3	Protein Coding	1
5	PTGER4	Prostaglandin E Receptor 4	Protein Coding	1
6	PTGFR	Prostaglandin F Receptor	Protein Coding	1
7	PTGIR	Prostaglandin I2 Receptor	Protein Coding	1
8	PTGIS	Prostaglandin I2 Synthase	Protein Coding	1
9	PTGS1	Prostaglandin-Endoperoxide Synthase 1	Protein Coding	1
10	PTGS2	Prostaglandin-Endoperoxide Synthase 2	Protein Coding	1
11	CACNA1F	Calcium Voltage-Gated Channel Subunit Alpha1 F	Protein Coding	1
12	CACNA1S	Calcium Voltage-Gated Channel Subunit Alpha1 S	Protein Coding	1
13	VEGFA	Vascular Endothelial Growth Factor A	Protein Coding	1
14	CACNA2D1	Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 1	Protein Coding	1
15	CACNB1	Calcium Voltage-Gated Channel Auxiliary Subunit Beta 1	Protein Coding	1
16	CACNB2	Calcium Voltage-Gated Channel Auxiliary Subunit Beta 2	Protein Coding	1
17	CACNB3	Calcium Voltage-Gated Channel Auxiliary Subunit Beta 3	Protein Coding	1
18	CACNB4	Calcium Voltage-Gated Channel Auxiliary Subunit Beta 4	Protein Coding	1
19	CA9	Carbonic Anhydrase 9	Protein Coding	1
20	CA12	Carbonic Anhydrase 12	Protein Coding	1
21	CACNA1A	Calcium Voltage-Gated Channel Subunit Alpha1 A	Protein Coding	1
22	CACNA1B	Calcium Voltage-Gated Channel Subunit Alpha1 B	Protein Coding	1
23	CACNA1C	Calcium Voltage-Gated Channel Subunit Alpha1 C	Protein Coding	1
24	CACNA1D	Calcium Voltage-Gated Channel Subunit Alpha1 D	Protein Coding	1
25	CACNA1E	Calcium Voltage-Gated Channel Subunit Alpha1 E	Protein Coding	1
26	TBXA2R	Thromboxane A2 Receptor	Protein Coding	1
27	TBXAS1	Thromboxane A Synthase 1	Protein Coding	1
28	MMP9	Matrix Metallopeptidase 9	Protein Coding	1
29	CACNA2D2	Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 2	Protein Coding	1
30	PPARG	Peroxisome Proliferator Activated Receptor Gamma	Protein Coding	1
31	PTGES	Prostaglandin E Synthase	Protein Coding	1
32	KCNQ4	Potassium Voltage-Gated Channel Subfamily Q Member 4	Protein Coding	1
33	CDKN1A	Cyclin Dependent Kinase Inhibitor 1A	Protein Coding	1
34	CDKN1B	Cyclin Dependent Kinase Inhibitor 1B	Protein Coding	1
35	KCNQ1	Potassium Voltage-Gated Channel Subfamily Q Member 1	Protein Coding	1
36	KCNQ2	Potassium Voltage-Gated Channel Subfamily Q Member 2	Protein Coding	1
37	KCNQ3	Potassium Voltage-Gated Channel Subfamily Q Member 3	Protein Coding	1
38	PDK1	Pyruvate Dehydrogenase Kinase 1	Protein Coding	1
39	CACNA1I	Calcium Voltage-Gated Channel Subunit Alpha1 I	Protein Coding	1
40	CACNA1H	Calcium Voltage-Gated Channel Subunit Alpha1 H	Protein Coding	1
41	CACNA1G	Calcium Voltage-Gated Channel Subunit Alpha1 G	Protein Coding	1
42	ATP2A1	ATPase Sarcoplasmic/Endoplasmic Reticulum Ca2+ Transporting 1	Protein Coding	1
43	ATP2A2	ATPase Sarcoplasmic/Endoplasmic Reticulum Ca2+ Transporting 2	Protein Coding	1
44	ATP2A3	ATPase Sarcoplasmic/Endoplasmic Reticulum Ca2+ Transporting 3	Protein Coding	1
45	AKR1C3	Aldo-Keto Reductase Family 1 Member C3	Protein Coding	1
46	CASP3	Caspase 3	Protein Coding	1
47	CASP9	Caspase 9	Protein Coding	1
48	AKT1	AKT Serine/Threonine Kinase 1	Protein Coding	1
49	DDIT3	DNA Damage Inducible Transcript 3	Protein Coding	1
50	IGFBP3	Insulin Like Growth Factor Binding Protein 3	Protein Coding	1
51	KCNQ5	Potassium Voltage-Gated Channel Subfamily Q Member 5	Protein Coding	1
52	PLA2G2A	Phospholipase A2 Group IIA	Protein Coding	1
53	PLA2G4A	Phospholipase A2 Group IVA	Protein Coding	1
54	CTNNB1	Catenin Beta 1	Protein Coding	1
55	CACNA2D3	Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 3	Protein Coding	1
56	BCAR1	BCAR1 Scaffold Protein, Cas Family Member	Protein Coding	1
57	CACNA2D4	Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 4	Protein Coding	1
58	HPGDS	Hematopoietic Prostaglandin D Synthase	Protein Coding	1

Disorders associated with Celecoxib Pathway, Pharmacodynamics SuperPath

according to GeneCards Suite gene sharing

#	Disorder	Type	Genes	Score
1	Seizures, benign familial neonatal, 2	Enrichment	KCNQ2, KCNQ3	4.75
2	Self-limited neonatal epilepsy	Enrichment	KCNQ2, KCNQ3	4.75
3	Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures	Enrichment	CACNA1A, CACNA1C	4.27
4	Self-limited infantile epilepsy	Enrichment	KCNQ2, KCNQ3	3.75
5	Congenital short qt syndrome	Enrichment	CACNA2D1, KCNQ1	3.75
6	Brugada syndrome	Enrichment	CACNA1C, CACNA2D1, CACNB2	3.75
7	Long qt syndrome	Enrichment	CACNA1C, CACNA1S, KCNQ1	3.51
8	Multiple endocrine neoplasia, type i	Enrichment	CDKN1A, CDKN1B	3.43
9	Developmental and epileptic encephalopathy	Enrichment	CACNA1E, CACNA2D2, KCNQ2	3.32
10	Colorectal cancer	Enrichment	AKT1, CTNNB1, PLA2G2A, PPARG	3.29
11	Epilepsy, myoclonic juvenile	Enrichment	CACNB4, KCNQ3	3.02
12	Autosomal dominant non-syndromic intellectual disability	Enrichment	CACNA1I, KCNQ2, KCNQ5	2.90
13	Cone-rod dystrophy 6	Enrichment	CACNA1F, CACNA2D4	2.80
14	Undetermined early-onset epileptic encephalopathy	Enrichment	CACNA1A, CACNA1B, CACNA2D1	2.76
15	Proteus syndrome	Enrichment	AKT1	2.37
16	Hyperchlorhidrosis, isolated	Enrichment	CA12	2.37
17	Thyrotoxic periodic paralysis 1	Enrichment	CACNA1S	2.37
18	Asthma-related traits 1	Enrichment	PTGDR	2.37
19	Epilepsy, idiopathic generalized 9	Enrichment	CACNB4	2.37
20	Brugada syndrome 4	Enrichment	CACNB2	2.37
21	Ghosal hematodiaphyseal dysplasia	Enrichment	TBXAS1	2.37
22	Developmental and epileptic encephalopathy 7	Enrichment	KCNQ2	2.37
23	Episodic ataxia, type 5	Enrichment	CACNB4	2.37
24	Neurodevelopmental disorder with speech impairment and with or without seizures	Enrichment	CACNA1I	2.37
25	Congenital myopathy 18	Enrichment	CACNA1S	2.37
26	Bleeding disorder, platelet-type, 13	Enrichment	TBXA2R	2.37
27	Cone-rod dystrophy, x-linked, 3	Enrichment	CACNA1F	2.37
28	Retinal cone dystrophy 4	Enrichment	CACNA2D4	2.37
29	Primary aldosteronism, seizures, and neurologic abnormalities	Enrichment	CACNA1D	2.37
30	Microvascular complications of diabetes 1	Enrichment	VEGFA	2.37
31	Brugada syndrome 3	Enrichment	CACNA1C	2.37
32	Epilepsy, childhood absence 6	Enrichment	CACNA1H	2.37
33	Malignant hyperthermia 5	Enrichment	CACNA1S	2.37
34	Neuroendocrine tumor	Enrichment	CDKN1B	2.37
35	Sinoatrial node dysfunction and deafness	Enrichment	CACNA1D	2.37
36	Cytosolic phospholipase-a2 alpha deficiency associated bleeding disorder	Enrichment	PLA2G4A	2.37
37	Cowden syndrome 6	Enrichment	AKT1	2.37
38	Spinocerebellar ataxia 42	Enrichment	CACNA1G	2.37
39	Developmental and epileptic encephalopathy 110	Enrichment	CACNA2D1	2.37
40	Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits	Enrichment	CACNA1G	2.37
41	Developmental and epileptic encephalopathy 69	Enrichment	CACNA1E	2.37
42	Gastrointestinal ulceration, recurrent, with dysfunctional platelets	Enrichment	PLA2G4A	2.37
43	Hyperaldosteronism, familial, type iv	Enrichment	CACNA1H	2.37
44	Adenoid ameloblastoma	Enrichment	CTNNB1	2.37
45	Pparg-associated congenital generalized lipodystrophy	Enrichment	PPARG	2.37
46	Kcnq3-related disorders	Enrichment	KCNQ3	2.37
47	Rhabdomyolysis 2	Enrichment	ATP2A2	2.37
48	Conn's syndrome	Enrichment	CACNA1H	2.37
49	Sporadic hemiplegic migraine	Enrichment	CACNA1A	2.37
50	Atypical timothy syndrome	Enrichment	CACNA1C	2.37
51	Aldosterone-producing adenoma with seizures and neurological abnormalities	Enrichment	CACNA1D	2.37
52	Bleeding diathesis due to thromboxane synthesis deficiency	Enrichment	TBXA2R	2.37
53	Cryptogenic multifocal ulcerous stenosing enteritis	Enrichment	PLA2G4A	2.37
54	Timothy syndrome type 2	Enrichment	CACNA1C	2.37
55	Kcnq2-related disorders	Enrichment	KCNQ2	2.37
56	Periodic paralysis with transient compartment-like syndrome	Enrichment	CACNA1S	2.37
57	Timothy syndrome type 1	Enrichment	CACNA1C	2.37
58	Microcystic stromal tumor	Enrichment	CTNNB1	2.37
59	Cacna1c-related disorders	Enrichment	CACNA1C	2.37
60	Benign paroxysmal torticollis of infancy	Enrichment	CACNA1A	2.37
61	Congenital stationary night blindness	Enrichment	CACNA1F, CACNA2D4	2.37
62	Bladder cancer	Enrichment	CDKN1A, CTNNB1	2.17
63	Long qt syndrome 1	Enrichment	CACNA1C, KCNQ1	2.14
64	Seizures, benign familial neonatal, 1	Enrichment	KCNQ2	2.07
65	Acrokeratosis verruciformis	Enrichment	ATP2A2	2.07
66	Osteopathia striata with cranial sclerosis	Enrichment	CTNNB1	2.07
67	Brody disease	Enrichment	ATP2A1	2.07
68	Timothy syndrome	Enrichment	CACNA1C	2.07
69	Deafness, autosomal dominant 2a	Enrichment	KCNQ4	2.07
70	Carotid intimal medial thickness 1	Enrichment	PPARG	2.07
71	Night blindness, congenital stationary, type 2a	Enrichment	CACNA1F	2.07
72	Alternating hemiplegia of childhood 1	Enrichment	CACNA1A	2.07
73	Seizures, benign familial infantile, 3	Enrichment	KCNQ2	2.07
74	Multiple endocrine neoplasia, type iv	Enrichment	CDKN1B	2.07
75	Bleeding disorder, platelet-type, 14	Enrichment	TBXAS1	2.07
76	Long qt syndrome 8	Enrichment	CACNA1C	2.07
77	Intellectual developmental disorder, autosomal dominant 46	Enrichment	KCNQ5	2.07
78	Childhood hepatocellular carcinoma	Enrichment	CTNNB1	2.07
79	Cardiovascular system disease	Enrichment	KCNQ1	2.07
80	Benign familial neonatal epilepsy	Enrichment	KCNQ3	2.07
81	Metaphyseal anadysplasia 2	Enrichment	MMP9	2.07
82	Ichthyosis, congenital, autosomal recessive 10	Enrichment	KCNQ2	2.07
83	Congenital disorder of glycosylation, type iw, autosomal dominant	Enrichment	CACNA1D	2.07
84	Seizures, benign familial infantile, 5	Enrichment	KCNQ3	2.07
85	Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements	Enrichment	CACNA1B	2.07
86	Juvenile nasopharyngeal angiofibroma	Enrichment	CTNNB1	2.07
87	Metaphyseal anadysplasia	Enrichment	MMP9	2.07
88	Dfna2 nonsyndromic hearing loss	Enrichment	KCNQ4	2.07
89	Familial partial lipodystrophy	Enrichment	PPARG	2.07
90	Jervell-lange nielsen syndrome	Enrichment	KCNQ1	2.07
91	Benign neonatal seizures	Enrichment	KCNQ3	2.07
92	Teratoma	Enrichment	CTNNB1	2.07
93	Progressive bulbar palsy	Enrichment	CACNA1A	2.07
94	Ovarian cancer	Enrichment	AKT1, CDKN1B, CTNNB1	2.04
95	Eye disease	Enrichment	CACNA1F, CACNA2D4	2.01
96	Cerebral palsy	Enrichment	CACNA1A, CACNA1C	1.92
97	Darier-white disease	Enrichment	ATP2A2	1.89
98	Desmoid disease, hereditary	Enrichment	CTNNB1	1.89
99	Van der woude syndrome 1	Enrichment	CACNA1E	1.89
100	Asthma, nasal polyps, and aspirin intolerance	Enrichment	PTGER2	1.89
101	Atrial fibrillation, familial, 3	Enrichment	KCNQ1	1.89
102	Short qt syndrome 2	Enrichment	KCNQ1	1.89
103	Neurodevelopmental disorder with spastic diplegia and visual defects	Enrichment	CTNNB1	1.89
104	Anus, imperforate	Enrichment	CTNNB1	1.89
105	Exudative vitreoretinopathy 7	Enrichment	CTNNB1	1.89
106	Desmoid tumor	Enrichment	CTNNB1	1.89
107	Myxoid liposarcoma	Enrichment	DDIT3	1.89
108	Thyrotoxic periodic paralysis	Enrichment	CACNA1S	1.89
109	Hereditary episodic ataxia	Enrichment	CACNA1A	1.89
110	Migraine, familial hemiplegic, 1	Enrichment	CACNA1A	1.77
111	Jervell and lange-nielsen syndrome 1	Enrichment	KCNQ1	1.77
112	Spinocerebellar ataxia 6	Enrichment	CACNA1A	1.77
113	Aland island eye disease	Enrichment	CACNA1F	1.77
114	Developmental and epileptic encephalopathy 2	Enrichment	CACNA1A	1.77
115	Ventricular fibrillation, paroxysmal familial, 1	Enrichment	CACNA1C	1.77
116	Lipodystrophy, familial partial, type 3	Enrichment	PPARG	1.77
117	Pilomatrixoma	Enrichment	CTNNB1	1.77
118	Long qt syndrome 2	Enrichment	KCNQ1	1.77
119	Developmental and epileptic encephalopathy 42	Enrichment	CACNA1A	1.77
120	Leptin deficiency or dysfunction	Enrichment	PPARG	1.77
121	Alazami syndrome	Enrichment	CTNNB1	1.77
122	Congenital generalized lipodystrophy	Enrichment	PPARG	1.77
123	Cerebellar atrophy with seizures and variable developmental delay	Enrichment	CACNA2D2	1.77
124	Developmental and epileptic encephalopathy 52	Enrichment	CACNA1A	1.77
125	Atrial fibrillation	Enrichment	KCNQ1	1.77
126	Craniopharyngioma	Enrichment	CTNNB1	1.77
127	Pregnancy loss, recurrent 1	Enrichment	KCNQ1	1.77
128	Malignant hyperthermia	Enrichment	CACNA1S	1.77
129	Episodic ataxia	Enrichment	CACNA1A	1.77
130	Familial or sporadic hemiplegic migraine	Enrichment	CACNA1A	1.77
131	Primary hyperparathyroidism	Enrichment	CDKN1B	1.77
132	Episodic ataxia, type 2	Enrichment	CACNA1A	1.67
133	Exudative vitreoretinopathy 1	Enrichment	CTNNB1	1.67
134	Heart conduction disease	Enrichment	CACNA1C	1.67
135	Amblyopia	Enrichment	CACNA1F	1.67
136	Cardiac arrest	Enrichment	CACNA2D1	1.67
137	Spastic ataxia	Enrichment	CACNA1G, CACNB4	1.67
138	Hypokalemic periodic paralysis, type 1	Enrichment	CACNA1S	1.60
139	Weyers acrofacial dysostosis	Enrichment	CTNNB1	1.60
140	Adrenocortical carcinoma	Enrichment	CTNNB1	1.60
141	Breast adenocarcinoma	Enrichment	AKT1	1.60
142	Childhood absence epilepsy	Enrichment	CACNA1H	1.60
143	Silver-russell syndrome 1	Enrichment	KCNQ1	1.53
144	Brugada syndrome 1	Enrichment	CACNA2D1	1.53
145	Gallbladder cancer	Enrichment	CTNNB1	1.53
146	Lennox-gastaut syndrome	Enrichment	CACNA1A	1.47
147	Exudative vitreoretinopathy	Enrichment	CTNNB1	1.47
148	Alternating hemiplegia of childhood	Enrichment	CACNA1A	1.47
149	Difference of sex development	Enrichment	CACNA1A	1.47
150	Cone-rod dystrophy 2	Enrichment	CACNA1F, CACNA2D4	1.47
151	Developmental and epileptic encephalopathy 14	Enrichment	KCNQ2	1.42
152	Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies	Enrichment	CACNA1C	1.42
153	Adult hepatocellular carcinoma	Enrichment	CTNNB1	1.42
154	Primary hyperaldosteronism	Enrichment	CACNA1H	1.42
155	Cowden syndrome	Enrichment	AKT1	1.42
156	Breast cancer	Enrichment	AKT1, CACNA2D1	1.39
157	Familial colorectal cancer	Enrichment	PLA2G2A	1.38
158	Rare genetic deafness	Enrichment	KCNQ1, KCNQ4	1.35
159	Migraine with or without aura 1	Enrichment	CACNA1A	1.34
160	Epilepsy, idiopathic generalized	Enrichment	CACNA1H	1.34
161	Cardiac conduction defect	Enrichment	CACNA1C	1.30
162	Epicanthus	Enrichment	KCNQ2	1.30
163	Meningioma	Enrichment	AKT1	1.30
164	Congenital long qt syndrome	Enrichment	KCNQ1	1.30
165	Medulloblastoma	Enrichment	CTNNB1	1.23
166	Myopia	Enrichment	CACNA1F	1.21
167	Wolff-parkinson-white syndrome	Enrichment	KCNQ1	1.18
168	Gliosarcoma	Enrichment	PPARG	1.18
169	Hypertension, essential	Enrichment	PTGIS	1.15
170	Sudden infant death syndrome	Enrichment	KCNQ1	1.15
171	Polycystic liver disease	Enrichment	CTNNB1	1.15
172	Giant cell glioblastoma	Enrichment	PPARG	1.15
173	Autosomal dominant polycystic liver disease	Enrichment	CTNNB1	1.15
174	Beckwith-wiedemann syndrome	Enrichment	KCNQ1	1.13
175	Congenital nervous system abnormality	Enrichment	CACNA1A, CTNNB1	1.12
176	Nervous system disease	Enrichment	CACNA1A, CTNNB1	1.12
177	Congenital myopathy	Enrichment	CACNA1S	1.11
178	Centronuclear myopathy	Enrichment	CACNA1S	1.06
179	Hepatoblastoma	Enrichment	CTNNB1	1.06
180	Hepatocellular carcinoma	Enrichment	CTNNB1	1.05
181	Ear malformation	Enrichment	KCNQ1	1.01
182	Cardiomyopathy, familial hypertrophic, 1	Enrichment	CACNA1C	1.01
183	Familial atrial fibrillation	Enrichment	KCNQ1	1.01
184	Cone dystrophy	Enrichment	CACNA2D4	1.01
185	Developmental and epileptic encephalopathy 1	Enrichment	KCNQ2	0.99
186	Auditory neuropathy	Enrichment	CACNA1A	0.98
187	Strabismus	Enrichment	CACNA1A	0.96
188	Differentiated thyroid carcinoma	Enrichment	PPARG	0.93
189	Non-syndromic genetic deafness	Enrichment	KCNQ4	0.84
190	Benign epilepsy with centrotemporal spikes	Enrichment	KCNQ3	0.79
191	Type 2 diabetes mellitus	Enrichment	PPARG	0.78
192	Nonsyndromic hearing loss	Enrichment	KCNQ4	0.78
193	Centralopathic epilepsy	Enrichment	KCNQ3	0.77
194	Optic atrophy plus syndrome	Enrichment	CACNA1F	0.76
195	West syndrome	Enrichment	KCNQ2	0.76
196	Hereditary breast carcinoma	Enrichment	AKT1	0.76
197	Body mass index quantitative trait locus 11	Enrichment	PPARG	0.71
198	Rare autosomal dominant non-syndromic sensorineural deafness type dfna	Enrichment	KCNQ4	0.70
199	Hereditary breast ovarian cancer syndrome	Enrichment	BCAR1	0.68
200	Retinitis pigmentosa	Enrichment	CACNA1F, CACNA2D4	0.64
201	Hereditary retinal dystrophy	Enrichment	CACNA1F, CACNA2D4	0.45
202	Fundus dystrophy	Enrichment	CACNA1F, CACNA2D4	0.45
203	Microcephaly	Enrichment	CTNNB1	0.39
204	Complex neurodevelopmental disorder	Enrichment	CACNA1C	0.38
205	Inherited cancer-predisposing syndrome	Enrichment	CDKN1B	0.36

¹ WikiPathways

² PubChem

³ R&D Systems

⁴ Reactome

⁵ GeneGo (Thomson Reuters)

⁶ QIAGEN

⁷ PharmGKB

⁸ Cell Signaling Technology

⁹ Sino Biological

¹⁰ Tocris

¹¹ MalaCards

Celecoxib Pathway, Pharmacodynamics

Pathway Network for Celecoxib Pathway, Pharmacodynamics

Member Pathways for Celecoxib Pathway, Pharmacodynamics

Pathways in the Celecoxib Pathway, Pharmacodynamics SuperPath

Associated Genes for Celecoxib Pathway, Pharmacodynamics

Associated Disorders for Celecoxib Pathway, Pharmacodynamics

Disorders associated with Celecoxib Pathway, Pharmacodynamics SuperPath

STRING Interaction Network for Celecoxib Pathway, Pharmacodynamics

Sources for Celecoxib Pathway, Pharmacodynamics